Article focus {#section5-2046-3758.77.BJR-2017-0165.R1}
=============

-   Septic arthritis can cause significant joint destruction, with *Staphylococcus (S.) aureus* being the causative organism in most cases.

-   A previous *in vitro* study demonstrated that unspecified *S. aureus* toxins induced significant *in situ* chondrocyte death.

-   Studies by others investigating a variety of *S. aureus*-related infections have identified alpha (Hla)-, beta (Hlb)-, and gamma (Hlg)-haemolysins as potentially key damage-promoting toxins.

Key messages {#section6-2046-3758.77.BJR-2017-0165.R1}
============

-   *In situ* chondrocyte viability was assessed by confocal laser-scanning microscopy in bovine cartilage explants exposed to isogenic *S. aureus* mutants and their isolated culture supernatants.

-   The results strongly suggest that Hla alone was the key chondrocyte death-inducing toxin, with Hlb and Hlg having no significant effect.

-   This provides insight to support the development of future therapeutic strategies aimed at reducing the extent of cartilage damage during and after an episode of septic arthritis.

Strengths and limitations {#section7-2046-3758.77.BJR-2017-0165.R1}
=========================

-   This study enabled the focused assessment of the influence of Hla, Hlb, and Hlg on *in situ* chondrocyte viability in the absence of the complexities of a host immune response.

-   A limitation of the study is the extrapolation of conclusions from a bovine cartilage explant model to the clinical setting, as the sensitivity of human chondrocytes to *S. aureus* haemolysins may be different.

Introduction {#section8-2046-3758.77.BJR-2017-0165.R1}
============

Septic arthritis may lead to permanent damage of articular cartilage.^[@bibr1-2046-3758.77.BJR-2017-0165.R1],[@bibr2-2046-3758.77.BJR-2017-0165.R1]^ The current goal of treatment is to eradicate bacteria and associated toxins promptly, through a combination of joint lavage and intravenous antibiotics.^[@bibr3-2046-3758.77.BJR-2017-0165.R1]^ However, despite these strategies, some cartilage damage, and thus joint injury, develops in up to 50% of cases.^[@bibr4-2046-3758.77.BJR-2017-0165.R1]-[@bibr6-2046-3758.77.BJR-2017-0165.R1]^ Whilst a range of bacterial species may cause septic arthritis,^[@bibr4-2046-3758.77.BJR-2017-0165.R1]^ *Staphylococcus (S.) aureus* is most commonly implicated, accounting for 40% to 65% of cases.^[@bibr7-2046-3758.77.BJR-2017-0165.R1],[@bibr8-2046-3758.77.BJR-2017-0165.R1]^ *S. aureus* is a highly virulent Gram-positive pathogen known to produce an array of virulence factors,^[@bibr9-2046-3758.77.BJR-2017-0165.R1],[@bibr10-2046-3758.77.BJR-2017-0165.R1]^ which enable it to establish infection and contribute to the destruction of tissue.

Using a bovine cartilage explant model of *S. aureus*-induced septic arthritis, we previously identified that *S. aureus* toxins from both laboratory and clinical strains, isolated from patients with septic arthritis, induced significant chondrocyte death. However, the exact nature of these toxin(s) was not determined. Identification of the toxin(s) responsible for the chondrocyte death would represent an important step forward in the development of new therapeutic strategies aimed at reducing the extent of cartilage damage during and after an episode of septic arthritis.

Studies by others investigating a variety of *S. aureus*-related infections have implicated alpha (Hla)-, beta (Hlb)-, and gamma (Hlg)-haemolysins as key damage-promoting toxins,^[@bibr9-2046-3758.77.BJR-2017-0165.R1],[@bibr11-2046-3758.77.BJR-2017-0165.R1]-[@bibr15-2046-3758.77.BJR-2017-0165.R1]^ raising the possibility that these toxins may contribute to chondrocyte death. Hla forms cylindrical transmembrane heptameric pores,^[@bibr16-2046-3758.77.BJR-2017-0165.R1],[@bibr17-2046-3758.77.BJR-2017-0165.R1]^ which permit the influx and efflux of ions and small molecules, culminating in disruption of the ionic equilibrium, osmotic swelling, and the death of cells.^[@bibr18-2046-3758.77.BJR-2017-0165.R1]^ Similarly, Hlg is also a pore-forming toxin, although it has two functional bicomponent toxins (HlgAB and HlgCB) arising from three different subunits: HlgA, HlgB, and HlgC.^[@bibr19-2046-3758.77.BJR-2017-0165.R1]^ In contrast, Hlb is a Mg^2+^-dependent sphingomyelinase C that degrades sphingomyelin in the outer phospholipid layer of the cell membrane.^[@bibr20-2046-3758.77.BJR-2017-0165.R1]^

In the present work, we used the *in vitro* bovine cartilage explant model of *S. aureus*-induced septic arthritis to clarify the roles of Hla, Hlb, and Hlg on *in situ* chondrocyte viability.^[@bibr21-2046-3758.77.BJR-2017-0165.R1]^ This model avoids the complexities of a host immune response, permitting a clearer assessment of their direct effects on cartilage. Appropriate isogenic *S. aureus* mutant strains, with respect to Hla, Hlb, and Hlg expression, all originating from the laboratory 'wild-type' strain 8325-4 through site-directed mutagenesis, were specifically chosen to test the roles of these toxins. *S. aureus* 8325-4 is a well-characterized prophage-cured derivative of strain NCTC8325 that produces large amounts of Hla, Hlb, and Hlg,^[@bibr15-2046-3758.77.BJR-2017-0165.R1],[@bibr22-2046-3758.77.BJR-2017-0165.R1],[@bibr23-2046-3758.77.BJR-2017-0165.R1]^ and has chondrocyte-damaging potential of comparable potency to clinical strains of *S. aureus.*^[@bibr21-2046-3758.77.BJR-2017-0165.R1]^ Following cartilage explant culture with isogenic mutants or their culture supernatants, *in situ* chondrocyte viability was visualized and quantified by confocal laser-scanning microscopy (CLSM). The hypothesis was that pore-forming Hla alone was the dominant destructive toxin to *in situ* chondrocyte viability.

Materials and Methods {#section9-2046-3758.77.BJR-2017-0165.R1}
=====================

Biochemicals and solutions {#section10-2046-3758.77.BJR-2017-0165.R1}
--------------------------

Biochemicals were obtained from Invitrogen Ltd. (Paisley, United Kingdom) unless otherwise stated. The culture medium was serum-free Dulbecco's Modified Eagle's Medium (DMEM; catalogue no: 41966029). The fluorescent dyes 5-chloromethylfluorescein diacetate (CMFDA) and propidium iodide (PI), were prepared as 1 mM stocks using dimethyl sulphoxide or water, respectively. Formaldehyde solution (4% volume/volume in normal saline) was obtained from Fisher Scientific (Loughborough, United Kingdom). The standard bacterial culture media were tryptone soya agar (TSA) and tryptone soya broth (TSB; Oxoid Ltd, Basingstoke, United Kingdom). Tetracycline (2 µg/ml) and erythromycin (10 µg/ml) were obtained from Sigma-Aldrich (Gillingham, United Kingdom) and added to TSA and TSB depending on the 'mutation-coupled' antibiotic resistance profile of the isogenic mutant investigated ([Table I](#table1-2046-3758.77.BJR-2017-0165.R1){ref-type="table"}).^[@bibr14-2046-3758.77.BJR-2017-0165.R1],[@bibr22-2046-3758.77.BJR-2017-0165.R1]-[@bibr24-2046-3758.77.BJR-2017-0165.R1]^ Bacteria were stored at -80°C in 10% weight/volume skimmed milk (Oxoid Ltd).

###### 

*Staphylococcus aureus* 'haemolysin-knockout' isogenic mutant strains, originating from wild-type 8325-4, used in the study

  *Staphylococcus aureus* strain   Genotype                                    Phenotype/given name   Source/reference
  -------------------------------- ------------------------------------------- ---------------------- ----------------------------------------------------------
  8325-4                           Wild type                                   Hla^+^ Hlb^+^ Hlg^+^   Novick^[@bibr22-2046-3758.77.BJR-2017-0165.R1]^
  DU1090                           *hla*::Em^r^                                Hla^-^ Hlb^+^ Hlg^+^   O\'Reilly et al^[@bibr23-2046-3758.77.BJR-2017-0165.R1]^
  DU5720                           *hla*::Em^r^ *hlb*::φ42E                    Hla^-^ Hlb^-^ Hlg^+^   Patel et al^[@bibr24-2046-3758.77.BJR-2017-0165.R1]^
  DU5938                           *hlb*::φ42E *hla*::Em^r^ Δ*hlg*ABC::Tc^r^   Hla^-^ Hlb^-^ Hlg^-^   Nilsson et al^[@bibr14-2046-3758.77.BJR-2017-0165.R1]^
  DU5946                           *hlb*::φ42E Δ*hlg*ABC::Tc^r^                Hla^+^ Hlb^-^ Hlg^-^   Nilsson et al^[@bibr14-2046-3758.77.BJR-2017-0165.R1]^

Tc^r^, Tetracycline resistance; Em^r^, Erythromycin resistance; Hla, alpha-haemolysin; Hlb, beta-haemolysin; Hlg, gamma-haemolysin

Bacterial strains {#section11-2046-3758.77.BJR-2017-0165.R1}
-----------------

*S. aureus* strain 8325-4 and its associated isogenic mutants, containing combined mutations affecting Hla (*hla*::Em^r^), Hlb (*hlb*::φ42E), and Hlg (Δ*hlg*ACB::Tc^r^) synthesis ([Table I](#table1-2046-3758.77.BJR-2017-0165.R1){ref-type="table"}), were kindly provided by Professor Timothy J. Foster, Department of Microbiology, Trinity College, Dublin, Ireland. Mutants were established through site-directed mutagenesis of the Hla, Hlb, and Hlg genes, thereby rendering these genes inactive. All mutant strains were tested rigorously for phenotype and genotype at the time of creation by Southern hybridization and Western immunoblotting techniques.^[@bibr14-2046-3758.77.BJR-2017-0165.R1],[@bibr23-2046-3758.77.BJR-2017-0165.R1]-[@bibr25-2046-3758.77.BJR-2017-0165.R1]^

Erythromycin and tetracycline resistance associated with Hla and Hlg mutations, respectively, enabled the selective growth of specific mutants in antibiotic-loaded culture media. Nevertheless, prior to experimentation, the haemolysin production phenotype of the isogenic mutants was assessed by rabbit and sheep erythrocyte haemolysis assays. Fresh heparinized rabbit and sheep blood, obtained from the Scottish National Blood Transfusion Service (Penicuik, United Kingdom) and E&O Laboratories Ltd (Bonnybridge, United Kingdom), respectively, was used and red blood cell suspensions of approximately 5% haematocrit prepared in Hank's balanced salt solution (HBSS; pH 7.4).

Bacterial strains were streaked onto TSA plates with or without tetracycline (2 µg/ml) and erythromycin (10 µg/ml), as appropriate. Following 24 hours of incubation (37°C), TSB (10 ml) was inoculated with several individual bacterial colonies from the 24 hours TSA plate of a given bacterial strain, and cultured in a shaking incubator (37°C; 24 hours). The 24-hour cultures were then centrifuged (3400 × g; ten minutes) and supernatants harvested and filter-sterilized (0.2 µm). Supernatants (250 µl) were then added to 5% haematocrit suspension (250 µl), to give a haematocrit of 2.5%, and a 50% supernatant dilution, mixed gently and incubated (37°C) for 12 hours. The addition of HBSS (250 µl) to 5% haematocrit suspension (250 µl) acted as the control. Following incubation, samples were centrifuged (8000 × g; one minute) and aliquots were taken for determination of haemoglobin at Abs~540~ on a Nanodrop spectrophotometer (Thermo Fisher Scientific, Waltham, Massachusetts). Haemolysis, as a percentage of complete lysis, was calculated using the formula: (Abs~540~ of sample/Abs~540~ of 100% haemolysis) × 100%. Complete (100%) lysis was achieved by freezing (-20°C; 12 hours) and thawing appropriate 2.5% erythrocyte suspensions.

Preparation of bacterial aspirates {#section12-2046-3758.77.BJR-2017-0165.R1}
----------------------------------

When required, bacteria were thawed and streaked onto TSA plates with or without tetracycline (2 µg/ml) and erythromycin (10 µg/ml), as appropriate. Following 24 hours of incubation (37°C), TSB, containing antibiotics as required, was inoculated with several individual bacterial colonies from the 24-hour TSA plate of a given bacterial strain and cultured in a shaking incubator (37°C; 24 hours). Serial dilutions, to a maximum of 10^-6^, were performed on the 24-hour TSB culture in order to calculate the number of colony forming units (cfu) in 1 ml of 24-hour TSB. Thereafter, 100 µl of 10^-4^, 10^-5^, and 10^-6^ dilutions were spread onto TSA plates and incubated (37°C; 24 hours). Bacterial counts taken with a colony counter were performed on a number of cultures for each mutant strain that was studied and a count of approximately 1.0 × 10^9^ cfu/ml was routinely obtained. Based on these results, a fresh 24-hour culture of each strain grown in 10 ml TSB was diluted in DMEM to produce a final bacterial concentration of approximately 1.0 × 10^5^ cfu/ml DMEM.

Bovine osteochondral explants {#section13-2046-3758.77.BJR-2017-0165.R1}
-----------------------------

Metacarpophalangeal joints of three-year-old cows were washed, skinned, de-hoofed, and opened under sterile conditions within six hours of slaughter. Only healthy joints, with no evidence of cartilage damage or degeneration, were used. Osteochondral explants with full depth cartilage and attached subchondral bone, were harvested from the convex weight-bearing articular surface ([Fig. 1](#fig1-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). As the thickness, cell density, physical characteristics, and biochemical characteristics of articular cartilage have been shown to vary according to mechanical load,^[@bibr26-2046-3758.77.BJR-2017-0165.R1],[@bibr27-2046-3758.77.BJR-2017-0165.R1]^ explants were harvested from weight-bearing surfaces only in order to permit standardization.

![Photographs showing osteochondral explant harvesting from the bovine metacarpophalangeal joint: a) a sterile number-24 scalpel blade was used to acquire explants from the proximal limb; b) due to the convex nature of the number-24 scalpel blade, a steady forward and backward 'rocking' movement of the blade yielded explants with approximately 0.5 mm subchondral bone attached; c) the explants were immediately transferred to a vessel containing sterile Dulbecco's Modified Eagle's Medium using the harvesting blade i.e. a 'no touch' technique; d) an example of a typical oval explant (scale bar = 1 cm).](bonejointres-07-457-g001){#fig1-2046-3758.77.BJR-2017-0165.R1}

Bacterial culture studies {#section14-2046-3758.77.BJR-2017-0165.R1}
-------------------------

Explants from each joint were placed into separate tissue culture flasks containing DMEM. Then, 25 µl (approximately 2.5 × 10^3^ cfu) of a given isogenic mutant aspirate was injected into each flask. This concentration was chosen as control experiments identified that it produced a measurable degree of chondrocyte death within a reasonable time period that was neither overwhelming nor weak.^[@bibr21-2046-3758.77.BJR-2017-0165.R1]^ Flasks were then incubated (37°C; 5% CO~2~) for 40 hours.

Bacterial culture-supernatant studies {#section15-2046-3758.77.BJR-2017-0165.R1}
-------------------------------------

The 40-hour cultures of specified isogenic mutant strains were pooled and centrifuged (3400 × g; ten minutes). The supernatant, containing the toxins, was then harvested and filter-sterilized. Osteochondral explants were subsequently incubated (37°C; 5% CO~2~) with the supernatants (3 ml of neat supernatant per experimental container) for six hours.

Fluorescent probes and fixation {#section16-2046-3758.77.BJR-2017-0165.R1}
-------------------------------

At zero, 18, 24, and 40 hours (bacterial culture studies) or zero, two, four, and six hours (supernatant studies), explants were aseptically removed and trimmed so as to create two straight edges. Explants were then incubated (21°C; one hour) in penicillin (50  U/ml)-containing and streptomycin (50 µg/ml)-containing DMEM with CMFDA (10 µM) and PI (10 µM), to label living or dead chondrocytes green or red, respectively.^[@bibr28-2046-3758.77.BJR-2017-0165.R1],[@bibr29-2046-3758.77.BJR-2017-0165.R1]^ Explants were subsequently fixed in 4% formaldehyde prior to storage at 4°C in phosphate buffered saline (PBS). For CLSM, explants were secured to the base of a Petri dish with Blu Tack (Bostik, Leicester, United Kingdom) and re-submerged in PBS.

CLSM {#section17-2046-3758.77.BJR-2017-0165.R1}
----

An upright Zeiss LSM510 Axioskop (Carl Zeiss Ltd, Welwyn Garden City, United Kingdom) CLSM, fitted with a ×10/0.3 dry objective, was used to acquire optical sections of CMFDA- and PI-labelled *in situ* chondrocytes in either the axial or coronal plane to a depth of 100 µm using established methods.^[@bibr21-2046-3758.77.BJR-2017-0165.R1],[@bibr28-2046-3758.77.BJR-2017-0165.R1],[@bibr29-2046-3758.77.BJR-2017-0165.R1]^

Quantification of *in situ* chondrocyte death {#section18-2046-3758.77.BJR-2017-0165.R1}
---------------------------------------------

For reconstructed 3D axial projections, the percentage cell death (number of dead cells/total number of living and dead cells) × 100) was calculated within a 'field-of-view' region of interest (ROI)^[@bibr21-2046-3758.77.BJR-2017-0165.R1]^ measuring 921 µm × 461 µm × 100 µm (*x-y-z* axes, respectively) using Volocity 4 imaging software (Improvision, Coventry, United Kingdom), as previously described.^[@bibr21-2046-3758.77.BJR-2017-0165.R1]^ For coronal projections, the percentage cell death was quantified at 100 µm intervals, within a ROI measuring 921 µm × 100 µm × 100 µm (*x-y-z* axis, respectively), to a depth of 400 µm from the surface of the cartilage.^[@bibr21-2046-3758.77.BJR-2017-0165.R1]^ For each ROI, objects (individual cells) in both the green (living cells) and red (dead cells) channels were identified and counted using established methods.^[@bibr21-2046-3758.77.BJR-2017-0165.R1],[@bibr29-2046-3758.77.BJR-2017-0165.R1]^

Statistical analysis {#section19-2046-3758.77.BJR-2017-0165.R1}
--------------------

These were performed using SigmaPlot version 12 (Systat Software Inc, Chicago, Illinois); N referred to the number of feet obtained from independent animals (independent experiments) and n to the number of explants analyzed per experimental group at each timepoint. Replicates of explants for an experiment from the same animal were averaged to obtain a single observation for that animal. Parametric data were analyzed using one-way between-groups analysis of variance, with *post hoc* Dunnett's test, and unpaired Student's two-tailed *t*-tests. Wilcoxon signed-rank and Mann--Whitney U tests were used to analyze paired or non-paired non-parametric data, respectively. Data are presented as means and [sd]{.smallcaps} with the significance set at p \< 0.05.

Results {#section20-2046-3758.77.BJR-2017-0165.R1}
=======

Assessment of the toxin profiles of isogenic mutant strains {#section21-2046-3758.77.BJR-2017-0165.R1}
-----------------------------------------------------------

Hla, Hlb, and Hlg can be differentiated on the basis of the sensitivity of erythrocytes from different animal species to each toxin.^[@bibr30-2046-3758.77.BJR-2017-0165.R1]^ Hla is strongly haemolytic to rabbit erythrocytes, Hlb is strongly haemolytic to sheep erythrocytes, and Hlg is haemolytic to rabbit erythrocytes, although it is less efficient than Hla.^[@bibr14-2046-3758.77.BJR-2017-0165.R1],[@bibr31-2046-3758.77.BJR-2017-0165.R1],[@bibr32-2046-3758.77.BJR-2017-0165.R1]^ In order to determine the designated toxin production phenotypes of the isogenic mutant strains ([Table I](#table1-2046-3758.77.BJR-2017-0165.R1){ref-type="table"}), rabbit and sheep erythrocyte haemolysis assays were conducted ([Table II](#table2-2046-3758.77.BJR-2017-0165.R1){ref-type="table"}) and there was a significant difference between the supernatants for both the rabbit (p \< 0.001) and sheep (p \< 0.001) assays. The 8325-4 (Hla^+^Hlb^+^Hlg^+^) and Hla^+^Hlb^-^Hlg^-^ supernatants induced significant rabbit erythrocyte haemolysis (p \< 0.001 *vs* HBSS control) ([Table II](#table2-2046-3758.77.BJR-2017-0165.R1){ref-type="table"}). The Hla^-^Hlb^+^Hlg^+^ and Hla^-^Hlb^-^Hlg^+^ supernatants also produced significant (p \< 0.001) haemolysis but to a lesser extent. There was no evidence of rabbit erythrocyte haemolysis with the Hla^-^Hlb^-^Hlg^-^ supernatant. The 8325-4 (Hla^+^Hlb^+^Hlg^+^) and Hla^-^Hlb^+^Hlg^+^ supernatants induced significant sheep erythrocyte haemolysis (p \< 0.001). In contrast, no significant haemolysis was detected in the presence of the Hla^+^Hlb^-^Hlg^-^, Hla^-^Hlb^-^Hlg^+^, and Hla^-^Hlb^-^Hlg^-^ culture supernatants. All isogenic mutant strains therefore produced the appropriate haemolysin phenotypes. Furthermore, the results indicated that the mutation inactivating the production of a particular toxin had no influence on the synthesis of other toxins. Thus, the production of Hla was not affected by the defective genes for Hlb and Hlb, and *vice versa*.

###### 

The haemolytic activity of *Staphylococcus aureus* 8325-4 and isogenic mutant strain culture supernatants on rabbit and sheep erythrocytes; p-values represent supernatant *versus* Hank's balanced salt solution (HBSS) control by *post hoc* Dunnett's test (n = 3)

  Staphylococcus aureus strain   Phenotype              Mean rabbit erythrocyte haemolysis, % ([sd]{.smallcaps})   Mean sheep erythrocyte haemolysis, % ([sd]{.smallcaps})
  ------------------------------ ---------------------- ---------------------------------------------------------- ---------------------------------------------------------
  8325-4                         Hla^+^ Hlb^+^ Hlg^+^   *49.9* (0.9), p \< 0.001                                   *53.2* (1.0), p \< 0.001
  DU5946                         Hla^+^ Hlb^-^ Hlg^-^   *53.8* (1.7), p \< 0.001                                   *4.1* (0.7), p = 0.35
  DU1090                         Hla^-^ Hlb^+^ Hlg^+^   *28* (0.9), p \< 0.001                                     *51.1* (1.4), p \< 0.001
  DU5720                         Hla^-^ Hlb^-^ Hlg^+^   *26.5* (1.4), p \< 0.001                                   *2.3* (0.9), p = 0.32
  DU5938                         Hla^-^ Hlb^-^ Hlg^-^   *5* (0.6), p = 0.06                                        *1.8* (0.2), p = 0.08
  HBSS control                   \-                     *3.9* (0.3)                                                *3.2* (1.1)

Hla, alpha-haemolysin; Hlb, beta-haemolysin; Hlg, gamma-haemolysin

Toxins from wild-type *Staphylococcus aureus* 8325-4 caused rapid chondrocyte death {#section22-2046-3758.77.BJR-2017-0165.R1}
-----------------------------------------------------------------------------------

As a first step, in order to assess whether all three haemolysins may be involved in causing chondrocyte death, osteochondral explants were cultured in the presence of either the 8325-4 (Hla^+^Hlb^+^Hlg^+^) or Hla^-^Hlb^-^Hlg^-^ strains. Chondrocyte death over 40 hours was then quantified in axial CLSM images. In explants cultured with *S. aureus* 8325-4 (Hla^+^Hlb^+^Hlg^+^), there was significant chondrocyte death at each timepoint ([Fig. 2a](#fig2-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). Between 24 and 40 hours, there was a substantial reduction in chondrocyte viability with 66.2% ([sd]{.smallcaps} 20.1%) (p = 0.029) cell death at 40 hours. In comparison, there was no significant chondrocyte death at 40 hours in those explants exposed to the Hla^-^Hlb^-^Hlg^-^ strain (6.7% ([sd]{.smallcaps} 8.9%); p = 0.11; zero hours *vs* 40 hours). Thus, one, all, or a combination of these haemolysins were responsible for chondrocyte death.

![Graphs showing the induction of chondrocyte death by *Staphylococcus aureus* haemolysins. a) Osteochondral explants cultured in the presence of the 8325-4 strain demonstrated significantly greater chondrocyte death at all timepoints. In comparison, chondrocyte death in the presence of the Hla^-^Hlb^-^Hlg^-^ strain was minimal (N = 4 (n* *= 8); \*p \< 0.05, 8325-4 *vs* Hla^-^Hlb^-^Hlg^-^ strain by Mann--Whitney U test). Confocal laser-scanning microscopy (CLSM) images displayed the marked difference between the two strains at 40 hours. b) Osteochondral explants exposed to the 8325-4 culture supernatant demonstrated rapid and significant chondrocyte death over six hours compared with explants exposed to the Hla^-^Hlb^-^Hlg^-^ supernatant (N = 4 (n = 8); \*p \< 0.05, 8325-4 *vs* Hla^-^Hlb^-^Hlg^-^ supernatant by Mann--Whitney U test). The CLSM images demonstrate the marked difference between the two supernatants at six hours (in this and subsequent figures, the scale bar = 100 µm).](bonejointres-07-457-g002){#fig2-2046-3758.77.BJR-2017-0165.R1}

In order to assess the chondrocyte death-inducing potential of the 40 hours 8325-4 (Hla^+^Hlb^+^Hlg^+^) culture toxins independent of bacteria, a toxin-rich supernatant was prepared. Fresh osteochondral explants were exposed to either 8325-4 (Hla^+^Hlb^+^Hlg^+^) or Hla^-^Hlb^-^Hlg^-^ culture supernatants. In comparison with explants exposed to the Hla^-^Hlb^-^Hlg^-^ supernatant, those exposed to the 8325-4 (Hla^+^Hlb^+^Hlg^+^) supernatant demonstrated significant chondrocyte death at each timepoint ([Fig. 2b](#fig2-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). There was no measurable chondrocyte death at any timepoint in explants exposed to the Hla^-^Hlb^-^Hlg^-^ supernatant.

Hlb and Hlg induced minimal *in situ* chondrocyte death {#section23-2046-3758.77.BJR-2017-0165.R1}
-------------------------------------------------------

In order to evaluate the contributions of Hlb and Hlg, osteochondral explants were cultured with the Hla^-^Hlb^+^Hlg^+^ and Hla^-^Hlb^-^Hlg^+^ strains. The Hla^-^Hlb^-^Hlg^-^ strain was used as a control as it does not cause significant chondrocyte death over 40 hours ([Fig. 2a](#fig2-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). Although slightly more chondrocyte death occurred in explants exposed to the Hla^-^Hlb^-^Hlg^+^ strain at 24 hours (p = 0.027), the level of chondrocyte death was very low (1.3% ([sd]{.smallcaps} 0.5%)) and at the detection limit ([Fig. 3](#fig3-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). By 40 hours, there was no difference between the strains (p = 0.12). Thus, Hlb and Hlg had no significant role in the induction of *in situ* chondrocyte death.

![Graph showing that beta-haemolysin (Hlb) and gamma-haemolysin (Hlg) had a negligible effect on *in situ* chondrocyte viability. Osteochondral explants cultured in the presence of the Hla^-^Hlb^-^Hlg^-^, Hla^-^Hlb^+^Hlg^+^, and Hla^-^Hlb^-^Hlg^+^ strains exhibited minimal chondrocyte death at each timepoint (N = 4 (n = 8); p-values are shown from one-way analysis of variance; \*p \< 0.05 *vs* Hla^-^Hlb^-^Hlg^-^ strain by *post hoc* Dunnett's test). The confocal laser-scanning microscopy images show examples of the chondrocyte death induced by each strain at 40 hours.](bonejointres-07-457-g003){#fig3-2046-3758.77.BJR-2017-0165.R1}

Hla alone induced significant and rapid *in situ* chondrocyte death {#section24-2046-3758.77.BJR-2017-0165.R1}
-------------------------------------------------------------------

In order to test whether Hla alone was a key damaging toxin to *in situ* chondrocyte viability, explants were cultured in the presence of 8325-4 (Hla^+^Hlb^+^Hlg^+^), Hla^+^Hlb^-^Hlg^-^, or Hla^-^Hlb^-^Hlg^-^ (control). Compared with the control, explants exposed to 8325-4 (Hla^+^Hlb^+^Hlg^+^) and Hla^+^Hlb^-^Hlg^-^ exhibited significant chondrocyte death at each timepoint ([Fig. 4](#fig4-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). Although there was a significant difference between the 8325-4 (Hla^+^Hlb^+^Hlg^+^) and Hla^+^Hlb^-^Hlg^-^ strains at 24 hours (p = 0.01), there was no difference at 40 hours (p = 0.2, unpaired Student's two-tailed *t*-test).

![Graph showing that the 8325-4 and Hla^+^Hlb^-^Hlg^-^ strains had comparable potencies. In comparison with the Hla^-^Hlb^-^Hlg^-^strain control group, the 8325-4 and Hla^+^Hlb^-^Hlg^-^ strains induced similar chondrocyte death over the experimental period (N = 4 (n = 8); p-values are shown from one-way analysis of variance; \*p \< 0.05; †p \< 0.01; ‡p \< 0.001 *vs* Hla^-^Hlb^-^Hlg^-^ strain by *post hoc* Dunnett's test). Confocal laser-scanning microscopy images represent the chondrocyte death induced by each strain at 40 hours.](bonejointres-07-457-g004){#fig4-2046-3758.77.BJR-2017-0165.R1}

In order to test further whether Hla was the sole cause of chondrocyte death, explants were exposed to the 40 hours culture supernatants of the 8325-4 (Hla^+^Hlb^+^Hlg^+^) and Hla^-^Hlb^+^Hlg^+^ strains, where the only difference between the supernatants was the presence or absence of Hla, respectively. There was negligible chondrocyte death in the explants exposed to the Hla^-^Hlb^+^Hlg^+^ supernatant, while there was significant chondrocyte death at each timepoint in those exposed to the 8325-4 (Hla^+^Hlb^+^Hlg^+^) supernatant ([Fig. 5](#fig5-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). These results therefore confirmed that *S. aureus* Hla was the only toxin capable of inducing substantial and significant *in situ* chondrocyte death. Other bacterial products/toxins had a negligible effect on chondrocyte viability, as shown by the lack of effect when the explants were cultured in Hla^-^Hlb^+^Hlg^+^ or Hla^-^Hlb^-^Hlg^-^ supernatants ([Figs 2b](#fig2-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"} and [5](#fig5-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}).

![Graph showing that alpha-haemolysin (Hla) alone affected *in situ* chondrocyte viability. Osteochondral explants cultured with Hla^-^Hlb^+^Hlg^+^ supernatant were compared with those cultured with 8325-4 supernatant. The only difference between the two culture supernatants was the presence or absence of Hla. There was significant chondrocyte death at each timepoint in explants exposed to the 8325-4 supernatant in comparison with those exposed to the Hla^-^Hlb^+^Hlg^+^ supernatant (N = 4 (n = 8); \*p \< 0.05; ‡p \< 0.001 by unpaired Student's two-tailed *t*-test). The confocal laser-scanning microscopy images display the influence of Hla on *in situ* chondrocyte viability.](bonejointres-07-457-g005){#fig5-2046-3758.77.BJR-2017-0165.R1}

Hla-induced chondrocyte death commenced within the superficial zone of cartilage {#section25-2046-3758.77.BJR-2017-0165.R1}
--------------------------------------------------------------------------------

The axial studies described above involved imaging osteochondral explants to a depth of approximately 100 µm from the articular surface, thereby permitting quantification of chondrocyte death within the entirety of the superficial zone (SZ) and a portion of the middle zone (MZ). In order to establish whether Hla-induced chondrocyte death started in the SZ and to assess whether Hlb and Hlg did not selectively induce chondrocyte death within deeper layers of cartilage (i.e. cell death \> 100 µm that would not be detected on axial imaging due to depth limitations), a coronal study was performed. Osteochondral explants were exposed to 8325-4 (Hla^+^Hlb^+^Hlg^+^), Hla^+^Hlb^-^Hlg^-^, Hla^-^Hlb^+^Hlg^+^, or Hla^-^Hlb^-^Hlg^-^ strain culture supernatants and imaged coronally. As reported previously,^[@bibr29-2046-3758.77.BJR-2017-0165.R1]^ a dead cell artefact was induced by the scalpel cut at zero hours ([Fig. 6](#fig6-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}).

![Graphs showing the pattern of alpha-haemolysin-induced chondrocyte death. Over 40 hours, compared with the a) Hla^-^Hlb^-^Hlg^-^ control group, there was significantly more chondrocyte death within the first 100 µm of explants exposed to the b) Hla-containing 8325-4 and c) Hla^+^Hlb^-^Hlg^-^ supernatants. d) There was no change in chondrocyte viability in explants exposed to the Hla^-^Hlb^+^Hlg^+^ strain supernatant (N = 4 (n = 8); ‡p \< 0.001 *vs* Hla^-^Hlb^-^Hlg^-^ strain supernatant by *post hoc* Dunnett's test). a) to d) The confocal laser-scanning microscopy inserts show examples of the zonal pattern of chondrocyte death following explant exposure to the 40-hour culture supernatant of the strain indicated.](bonejointres-07-457-g006){#fig6-2046-3758.77.BJR-2017-0165.R1}

Explants exposed to the Hla^-^Hlb^-^Hlg^-^ supernatant (control) exhibited no significant chondrocyte death above zero-hour values for each depth interval at six hours (p = 0.07) ([Fig. 6a](#fig6-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). Compared with the control group, explants exposed to the 8325-4 (Hla^+^Hlb^+^Hlg^+^) and Hla^+^Hlb^-^Hlg^-^ supernatants exhibited significant chondrocyte death (p \< 0.001) within the first depth interval (0 µm to 100 µm) ([Figs 6a](#fig6-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"} to [6c](#fig6-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). In those explants exposed to the Hla^-^Hlb^+^Hlg^+^ supernatant, there was no change in chondrocyte viability within the first depth interval (p = 0.28) or throughout the analyzed depth of cartilage ([Fig. 6d](#fig6-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}). This further confirmed that Hlb and Hlg had no significant role in the induction of chondrocyte death within the SZ, but also that Hlb and Hlg did not specifically induce chondrocyte death within deeper layers.

Discussion {#section26-2046-3758.77.BJR-2017-0165.R1}
==========

Our main finding was that *S. aureus* Hla alone could induce rapid chondrocyte death, starting in the SZ of cartilage, whereas, in comparison, Hlb and Hlg induced negligible chondrocyte death. The lethal influence of Hla on chondrocyte viability is of potential importance in understanding the mechanism of cartilage destruction both during and after an episode of *S. aureus*-induced septic arthritis.

As chondrocytes in healthy cartilage do not normally divide once skeletal maturity is achieved,^[@bibr33-2046-3758.77.BJR-2017-0165.R1]^ chondrocyte loss may ultimately have catastrophic consequences. Chondrocytes govern the turnover of matrix and thus cartilage devoid of chondrocytes will ultimately degrade, as maintenance of the matrix will be lost. This has been demonstrated in an *in vivo* study on rabbits by Simon et al,^[@bibr34-2046-3758.77.BJR-2017-0165.R1]^ in which the long-term effect of localized cryotherapy-induced chondrocyte death was investigated. Six months after the cryotherapy, the cartilage was structurally intact despite the absence of viable chondrocytes. However, by 12 months there was extensive cartilage fibrillation and softening, changes considered to be amongst the first macroscopic changes associated with degenerative joint disease.^[@bibr35-2046-3758.77.BJR-2017-0165.R1]^

Due to a lack of long-term prospective radiographic surveillance studies, how long it takes for cartilage destruction to become apparent following a supposedly treated episode of septic arthritis is currently not known. However, the potential rapid consequences of inadequately treated septic arthritis caused by *S. aureus* may be more evident. In a case report by Kim et al,^[@bibr36-2046-3758.77.BJR-2017-0165.R1]^ the details of a case of 'missed' septic arthritis of the hip in a 61-year-old woman were presented. At the time of the onset of symptoms, plain radiographs were reported as normal and the diagnosis of 'hip sprain' was proposed. Two months later, with progressively worsening symptoms, aspiration of the hip confirmed *S. aureus*-induced sepsis. By this stage, however, repeat radiographs demonstrated complete loss of joint space and bone destruction. Whilst such an untreated case is rare, it highlights the cartilage-damaging potential of *S. aureus*-induced septic arthritis and the importance of early diagnosis and treatment. Given the lethal role of Hla observed in the current study, it is recommended that infected synovial fluid be removed promptly from the affected joint, with surgical washout probably offering the most comprehensive form of lavage.

The *in vitro* findings presented here differed from previous *in vivo* studies and it is important to consider possible explanations. Using murine models of septic arthritis caused by *S. aureus*, Gemmell et al^[@bibr15-2046-3758.77.BJR-2017-0165.R1]^ and Nilsson et al^[@bibr14-2046-3758.77.BJR-2017-0165.R1]^ concluded that Hla in combination with protein A and Hlg, respectively, were crucial for the development and progression of *S. aureus*-induced septic arthritis. Protein A is a cell wall surface protein that aids *S. aureus* survival in the presence of a host immune response by binding the Fc portion of IgG and the Fc receptors of polymorphonuclear leukocytes, thereby preventing bacterial opsonization and phagocytosis.^[@bibr9-2046-3758.77.BJR-2017-0165.R1],[@bibr37-2046-3758.77.BJR-2017-0165.R1]^ However, the experimental model in the current study included no immune response. Furthermore, purified Hla has been shown to lyse eukaryotic cells, including erythrocytes^[@bibr38-2046-3758.77.BJR-2017-0165.R1]^ and monocytic cells,^[@bibr39-2046-3758.77.BJR-2017-0165.R1]^ thereby demonstrating lytic activity in the absence of protein A and other bacterial products. Thus, it seems probable that the Hla-induced chondrocyte death observed in the present study was independent of protein A. Whilst Hlg induced negligible chondrocyte death ([Fig. 3](#fig3-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}), it is possible that it may play a destructive role *in vivo* as it may stimulate the release of inflammatory mediators.^[@bibr14-2046-3758.77.BJR-2017-0165.R1],[@bibr40-2046-3758.77.BJR-2017-0165.R1],[@bibr41-2046-3758.77.BJR-2017-0165.R1]^

The establishment of Hla as a chondrocyte death-inducing toxin and the recent identification of A-disintegrin and metalloprotease 10 (ADAM10) as its receptor on eukaryotic cells,^[@bibr17-2046-3758.77.BJR-2017-0165.R1],[@bibr42-2046-3758.77.BJR-2017-0165.R1]-[@bibr44-2046-3758.77.BJR-2017-0165.R1]^ offers potential future therapeutic targets. By attempting to block the activity of Hla, for example by Hla-neutralizing antibodies or selective blockade of ADAM10, it is possible that chondrocyte death may be reduced during septic arthritis caused by *S. aureus*, thereby minimizing the extent of subsequent cartilage loss. Support for this comes from a murine study of pneumonia caused by *S. aureus*,^[@bibr45-2046-3758.77.BJR-2017-0165.R1]^ which demonstrated protection in those animals immunized with a mutant form of Hla (Hla~H35L~) that was unable to form transmembrane pores and thus unable to lyse cells. The administration of Hla-specific antibodies to non-vaccinated animals also conferred protection. This is corroborated further in a recent study by Corrado et al^[@bibr46-2046-3758.77.BJR-2017-0165.R1]^ in which the administration of a four-component vaccine, comprising five *S. aureus* antigens including a genetically detoxified derivative of Hla,^[@bibr10-2046-3758.77.BJR-2017-0165.R1]^ to a murine model of *S. aureus* septic arthritis conferred protection to bacterial-mediated cellular toxicity.

A further potential therapeutic target is the Hla-induced cell death pathway following formation of the Hla pore through the plasma membrane. It is currently believed that the formation of pores triggers a cascade of events that ultimately culminates in cell death.^[@bibr18-2046-3758.77.BJR-2017-0165.R1],[@bibr47-2046-3758.77.BJR-2017-0165.R1]-[@bibr49-2046-3758.77.BJR-2017-0165.R1]^ It has been suggested that alterations in intracellular concentrations of Ca^2+^, Na^+^, and K^+^ may be key events in the Hla-induced cell death pathway after the formation of pores.^[@bibr50-2046-3758.77.BJR-2017-0165.R1]^ However, there remains some uncertainty as to the exact roles of these ions. Some studies have suggested that the influx of Ca^2+^ through the membrane-spanning Hla pore is the main trigger of cellular death mechanisms,^[@bibr48-2046-3758.77.BJR-2017-0165.R1]^ while others have suggested that Hla pores do not permit the passage of divalent cations and that the important primary trigger is the influx of Na^+^ coupled with the efflux of K^+^.^[@bibr49-2046-3758.77.BJR-2017-0165.R1],[@bibr51-2046-3758.77.BJR-2017-0165.R1]^ Regardless, the influx of cations is accompanied by water, leading to swelling and lysis of cells. In addition to disturbance of the ionic equilibrium, activation of stress-signalling pathways, and the egress of vital molecules, such as adenosine triphosphate from the cell membrane are also thought to contribute to cell death.^[@bibr18-2046-3758.77.BJR-2017-0165.R1],[@bibr47-2046-3758.77.BJR-2017-0165.R1]-[@bibr49-2046-3758.77.BJR-2017-0165.R1]^ However, the mechanism of Hla-induced cell death may be concentration dependent as Jonas et al^[@bibr52-2046-3758.77.BJR-2017-0165.R1]^ identified that when isolated peripheral blood human T lymphocytes were exposed to a high concentration of Hla, the plasma membrane became permeable to Ca^2+^. In contrast, when the cells were exposed to low concentrations of Hla, the plasma membrane was found to be impermeable to Ca^2+^, thereby suggesting that Hla pore size, and indeed the probable mechanism of cell death, may be dependent on the concentration of Hla. Clearly, a further understanding of this pathway is required before this avenue can be explored as a potential therapeutic target.

We used a bovine cartilage explant model of *S. aureus*-induced septic arthritis and live- and dead-cell CLSM imaging in this study to assess the influence of Hla, Hlb, and Hlg on *in situ* chondrocyte viability. The rationale behind such a model and its advantages have been discussed previously.^[@bibr21-2046-3758.77.BJR-2017-0165.R1]^ A potential limitation is the extrapolation of conclusions from this model of septic arthritis to the clinical setting as the sensitivity of human chondrocytes to *S. aureus* haemolysins may be different. Whilst it is possible that human chondrocytes may be sensitive to Hlb and Hlg, Chubinskaya et al^[@bibr53-2046-3758.77.BJR-2017-0165.R1]^ have demonstrated greater ADAM10 expression in human chondrocytes compared with bovine chondrocytes and thus the impact of Hla on human chondrocytes may be more important. They have also reported increased ADAM10 expression by SZ chondrocytes compared with chondrocytes from deeper layers in healthy human cartilage.^[@bibr53-2046-3758.77.BJR-2017-0165.R1]^ This may offer an additional explanation, beyond that of the close proximity of SZ chondrocytes to the culture medium harbouring Hla, for the observed zonal pattern of chondrocyte death in both the current ([Fig. 6](#fig6-2046-3758.77.BJR-2017-0165.R1){ref-type="fig"}) and previous studies.^[@bibr21-2046-3758.77.BJR-2017-0165.R1]^ In any event, future work should be directed at assessing the sensitivity of *in situ* human chondrocytes to Hla, Hlb, and Hlg toxins.

Using an established *in vitro* model of *S. aureu*s-induced septic arthritis, we have demonstrated that Hla alone has a rapid and lethal influence on *in situ* chondrocytes, with Hlb and Hlg having no significant effect on their viability. The identification of Hla as the key destructive toxin to chondrocytes may provide insight to support the development of therapeutic strategies aimed at reducing the extent of cartilage damage during and after an episode of septic arthritis caused by *S. aureus*.
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